Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer Katherine K. BassMichael J. Mastrangelo REVIEW Pages: 1 - 12
Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres Jie MaJohn SamuelRagupathy Madiyalakan ORIGINAL ARTICLE Pages: 13 - 20
Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus Junji AkagiKazuhiro NakagawaMichio Ogawa ORIGINAL ARTICLE Pages: 21 - 31
Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells Kun LiMedi AdibzadehGraham Pawelec ORIGINAL ARTICLE Pages: 32 - 38
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01 Helma M. PrinssenCarla F. M. MolthoffAlan C. Perkins ORIGINAL ARTICLE Pages: 39 - 46
Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells Megumi MiyamotoYukihiro ShimizuAkiharu Watanabe ORIGINAL ARTICLE Pages: 47 - 57
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma Nitya G. ChakrabortyJonathan R. SpornBijay Mukherji ORIGINAL ARTICLE Pages: 58 - 64